nodes	percent_of_prediction	percent_of_DWPC	metapath
Levofloxacin—CYP3A4—bone cancer	0.38	1	CbGaD
Levofloxacin—TOP2A—Epirubicin—bone cancer	0.187	0.421	CbGbCtD
Levofloxacin—TOP2A—Doxorubicin—bone cancer	0.0992	0.224	CbGbCtD
Levofloxacin—SLC22A2—Cisplatin—bone cancer	0.0744	0.168	CbGbCtD
Levofloxacin—SLC22A6—Methotrexate—bone cancer	0.0289	0.0651	CbGbCtD
Levofloxacin—ABCB1—Cisplatin—bone cancer	0.0198	0.0447	CbGbCtD
Levofloxacin—ABCB1—Doxorubicin—bone cancer	0.0133	0.03	CbGbCtD
Levofloxacin—ABCB1—Methotrexate—bone cancer	0.0129	0.029	CbGbCtD
Levofloxacin—CYP3A4—Doxorubicin—bone cancer	0.00795	0.0179	CbGbCtD
Levofloxacin—TOP2A—Gastric Cancer Network 1—C21orf33—bone cancer	0.00304	0.149	CbGpPWpGaD
Levofloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—T—bone cancer	0.00175	0.086	CbGpPWpGaD
Levofloxacin—CYP1A2—Lidocaine metabolism—CYP3A4—bone cancer	0.00134	0.0657	CbGpPWpGaD
Levofloxacin—TOP2A—Idarubicin—Epirubicin—bone cancer	0.000558	0.173	CbGdCrCtD
Levofloxacin—TOP2A—Doxorubicin—Epirubicin—bone cancer	0.000558	0.173	CbGdCrCtD
Levofloxacin—TOP2A—Daunorubicin—Epirubicin—bone cancer	0.000558	0.173	CbGdCrCtD
Levofloxacin—ABCB1—Codeine and Morphine Metabolism—CYP3A4—bone cancer	0.000554	0.0272	CbGpPWpGaD
Levofloxacin—ABCB1—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.000519	0.0254	CbGpPWpGaD
Levofloxacin—ABCB1—HIF-1-alpha transcription factor network—CITED2—bone cancer	0.000518	0.0254	CbGpPWpGaD
Levofloxacin—TOP2A—Epirubicin—Doxorubicin—bone cancer	0.000516	0.16	CbGdCrCtD
Levofloxacin—TOP2A—Daunorubicin—Doxorubicin—bone cancer	0.000516	0.16	CbGdCrCtD
Levofloxacin—TOP2A—Idarubicin—Doxorubicin—bone cancer	0.000516	0.16	CbGdCrCtD
Levofloxacin—CYP1A2—Aflatoxin B1 metabolism—CYP3A4—bone cancer	0.000492	0.0241	CbGpPWpGaD
Levofloxacin—CYP1A2—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.00044	0.0216	CbGpPWpGaD
Levofloxacin—TOP2A—Circadian rythm related genes—TNFRSF11A—bone cancer	0.000416	0.0204	CbGpPWpGaD
Levofloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—BRCA2—bone cancer	0.000341	0.0167	CbGpPWpGaD
Levofloxacin—CYP3A4—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.00034	0.0167	CbGpPWpGaD
Levofloxacin—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.00032	0.0157	CbGpPWpGaD
Levofloxacin—ABCB1—Drug Induction of Bile Acid Pathway—CYP3A4—bone cancer	0.000303	0.0149	CbGpPWpGaD
Levofloxacin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000298	0.0146	CbGpPWpGaD
Levofloxacin—TOP2A—Retinoblastoma (RB) in Cancer—DHFR—bone cancer	0.000294	0.0144	CbGpPWpGaD
Levofloxacin—CYP1A2—Fatty Acid Omega Oxidation—CYP3A4—bone cancer	0.000254	0.0125	CbGpPWpGaD
Levofloxacin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000238	0.0117	CbGpPWpGaD
Levofloxacin—CYP1A2—Estrogen metabolism—CYP3A4—bone cancer	0.000231	0.0113	CbGpPWpGaD
Levofloxacin—CYP1A2—Aflatoxin activation and detoxification—CYP3A4—bone cancer	0.000221	0.0109	CbGpPWpGaD
Levofloxacin—CYP1A2—Xenobiotics—CYP3A4—bone cancer	0.000212	0.0104	CbGpPWpGaD
Levofloxacin—TOP2A—Mitotic G1-G1/S phases—DHFR—bone cancer	0.000207	0.0102	CbGpPWpGaD
Levofloxacin—CYP1A2—Tamoxifen metabolism—CYP3A4—bone cancer	0.000204	0.01	CbGpPWpGaD
Levofloxacin—CYP1A2—Metapathway biotransformation—CYP4V2—bone cancer	0.00019	0.00929	CbGpPWpGaD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—WT1—bone cancer	0.000189	0.00924	CbGpPWpGaD
Levofloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—MDM2—bone cancer	0.000188	0.0092	CbGpPWpGaD
Levofloxacin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000184	0.009	CbGpPWpGaD
Levofloxacin—ABCB1—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000183	0.00896	CbGpPWpGaD
Levofloxacin—TOP2A—Gastric Cancer Network 2—EGFR—bone cancer	0.000179	0.00877	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle, Mitotic—ZW10—bone cancer	0.000178	0.00874	CbGpPWpGaD
Levofloxacin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000174	0.00854	CbGpPWpGaD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—SMO—bone cancer	0.00016	0.00786	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle—ZW10—bone cancer	0.000159	0.00782	CbGpPWpGaD
Levofloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CDK4—bone cancer	0.000155	0.00758	CbGpPWpGaD
Levofloxacin—TOP2A—Gastric Cancer Network 2—TP53—bone cancer	0.00015	0.00736	CbGpPWpGaD
Levofloxacin—CYP3A4—Metapathway biotransformation—CYP4V2—bone cancer	0.000146	0.00717	CbGpPWpGaD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—EZH2—bone cancer	0.000146	0.00716	CbGpPWpGaD
Levofloxacin—SLC22A4—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000141	0.00692	CbGpPWpGaD
Levofloxacin—TOP2A—Circadian rythm related genes—GNA11—bone cancer	0.000141	0.0069	CbGpPWpGaD
Levofloxacin—TOP2A—Circadian rythm related genes—EZH2—bone cancer	0.00014	0.00687	CbGpPWpGaD
Levofloxacin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000139	0.00681	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle, Mitotic—TUBB4B—bone cancer	0.000135	0.00662	CbGpPWpGaD
Levofloxacin—TOP2A—Retinoblastoma (RB) in Cancer—RB1—bone cancer	0.000134	0.00659	CbGpPWpGaD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—IL3—bone cancer	0.000133	0.00652	CbGpPWpGaD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CHEK2—bone cancer	0.000131	0.00643	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle, Mitotic—RFC1—bone cancer	0.000123	0.00601	CbGpPWpGaD
Levofloxacin—SLC22A4—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000122	0.00598	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle—TUBB4B—bone cancer	0.000121	0.00592	CbGpPWpGaD
Levofloxacin—CYP1A2—Estrogen Receptor Pathway—JUN—bone cancer	0.00012	0.00587	CbGpPWpGaD
Levofloxacin—Ciprofloxacin—CYP3A4—bone cancer	0.000119	0.544	CrCbGaD
Levofloxacin—TOP2A—Retinoblastoma (RB) in Cancer—MDM2—bone cancer	0.000115	0.00562	CbGpPWpGaD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	0.000111	0.00545	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle—RFC1—bone cancer	0.00011	0.00537	CbGpPWpGaD
Levofloxacin—CYP1A2—Tryptophan metabolism—CYP3A4—bone cancer	0.000109	0.00535	CbGpPWpGaD
Levofloxacin—TOP2A—Mitotic G1-G1/S phases—CDK4—bone cancer	0.000109	0.00533	CbGpPWpGaD
Levofloxacin—Haemoglobin—Epirubicin—bone cancer	0.000108	0.000704	CcSEcCtD
Levofloxacin—Jaundice—Doxorubicin—bone cancer	0.000108	0.000704	CcSEcCtD
Levofloxacin—Stomatitis—Doxorubicin—bone cancer	0.000108	0.000704	CcSEcCtD
Levofloxacin—Rhinitis—Epirubicin—bone cancer	0.000108	0.000703	CcSEcCtD
Levofloxacin—Conjunctivitis—Doxorubicin—bone cancer	0.000108	0.000702	CcSEcCtD
Levofloxacin—Hepatitis—Epirubicin—bone cancer	0.000107	0.000701	CcSEcCtD
Levofloxacin—Haemorrhage—Epirubicin—bone cancer	0.000107	0.000701	CcSEcCtD
Levofloxacin—Eye disorder—Methotrexate—bone cancer	0.000107	0.0007	CcSEcCtD
Levofloxacin—Tinnitus—Methotrexate—bone cancer	0.000107	0.000698	CcSEcCtD
Levofloxacin—Hypoaesthesia—Epirubicin—bone cancer	0.000107	0.000697	CcSEcCtD
Levofloxacin—Asthenia—Cisplatin—bone cancer	0.000107	0.000696	CcSEcCtD
Levofloxacin—Pharyngitis—Epirubicin—bone cancer	0.000107	0.000696	CcSEcCtD
Levofloxacin—Cardiac disorder—Methotrexate—bone cancer	0.000107	0.000695	CcSEcCtD
Levofloxacin—Urinary tract disorder—Epirubicin—bone cancer	0.000106	0.000692	CcSEcCtD
Levofloxacin—Oedema peripheral—Epirubicin—bone cancer	0.000106	0.00069	CcSEcCtD
Levofloxacin—Haematuria—Doxorubicin—bone cancer	0.000106	0.000689	CcSEcCtD
Levofloxacin—Connective tissue disorder—Epirubicin—bone cancer	0.000106	0.000689	CcSEcCtD
Levofloxacin—Urethral disorder—Epirubicin—bone cancer	0.000105	0.000687	CcSEcCtD
Levofloxacin—Hepatobiliary disease—Doxorubicin—bone cancer	0.000105	0.000683	CcSEcCtD
Levofloxacin—Epistaxis—Doxorubicin—bone cancer	0.000104	0.000681	CcSEcCtD
Levofloxacin—Angiopathy—Methotrexate—bone cancer	0.000104	0.00068	CcSEcCtD
Levofloxacin—Sinusitis—Doxorubicin—bone cancer	0.000104	0.000678	CcSEcCtD
Levofloxacin—Immune system disorder—Methotrexate—bone cancer	0.000104	0.000677	CcSEcCtD
Levofloxacin—Visual impairment—Epirubicin—bone cancer	0.000104	0.000675	CcSEcCtD
Levofloxacin—Mediastinal disorder—Methotrexate—bone cancer	0.000103	0.000675	CcSEcCtD
Levofloxacin—Agranulocytosis—Doxorubicin—bone cancer	0.000103	0.000674	CcSEcCtD
Levofloxacin—Chills—Methotrexate—bone cancer	0.000103	0.000672	CcSEcCtD
Levofloxacin—Diarrhoea—Cisplatin—bone cancer	0.000102	0.000663	CcSEcCtD
Levofloxacin—Erythema multiforme—Epirubicin—bone cancer	0.000102	0.000663	CcSEcCtD
Levofloxacin—Alopecia—Methotrexate—bone cancer	0.000101	0.000662	CcSEcCtD
Levofloxacin—Bradycardia—Doxorubicin—bone cancer	0.000101	0.00066	CcSEcCtD
Levofloxacin—Mental disorder—Methotrexate—bone cancer	0.000101	0.000656	CcSEcCtD
Levofloxacin—Eye disorder—Epirubicin—bone cancer	0.0001	0.000655	CcSEcCtD
Levofloxacin—Tinnitus—Epirubicin—bone cancer	0.0001	0.000654	CcSEcCtD
Levofloxacin—Erythema—Methotrexate—bone cancer	0.0001	0.000652	CcSEcCtD
Levofloxacin—Malnutrition—Methotrexate—bone cancer	0.0001	0.000652	CcSEcCtD
Levofloxacin—Haemoglobin—Doxorubicin—bone cancer	9.99e-05	0.000652	CcSEcCtD
Levofloxacin—Norfloxacin—CYP3A4—bone cancer	9.99e-05	0.456	CrCbGaD
Levofloxacin—Cardiac disorder—Epirubicin—bone cancer	9.97e-05	0.000651	CcSEcCtD
Levofloxacin—Flushing—Epirubicin—bone cancer	9.97e-05	0.000651	CcSEcCtD
Levofloxacin—Rhinitis—Doxorubicin—bone cancer	9.97e-05	0.00065	CcSEcCtD
Levofloxacin—Haemorrhage—Doxorubicin—bone cancer	9.94e-05	0.000649	CcSEcCtD
Levofloxacin—Hepatitis—Doxorubicin—bone cancer	9.94e-05	0.000649	CcSEcCtD
Levofloxacin—Hypoaesthesia—Doxorubicin—bone cancer	9.89e-05	0.000645	CcSEcCtD
Levofloxacin—Pharyngitis—Doxorubicin—bone cancer	9.87e-05	0.000644	CcSEcCtD
Levofloxacin—Urinary tract disorder—Doxorubicin—bone cancer	9.82e-05	0.00064	CcSEcCtD
Levofloxacin—Oedema peripheral—Doxorubicin—bone cancer	9.79e-05	0.000639	CcSEcCtD
Levofloxacin—Dysgeusia—Methotrexate—bone cancer	9.79e-05	0.000638	CcSEcCtD
Levofloxacin—Connective tissue disorder—Doxorubicin—bone cancer	9.77e-05	0.000637	CcSEcCtD
Levofloxacin—Angiopathy—Epirubicin—bone cancer	9.75e-05	0.000636	CcSEcCtD
Levofloxacin—Urethral disorder—Doxorubicin—bone cancer	9.75e-05	0.000636	CcSEcCtD
Levofloxacin—Immune system disorder—Epirubicin—bone cancer	9.71e-05	0.000633	CcSEcCtD
Levofloxacin—Mediastinal disorder—Epirubicin—bone cancer	9.68e-05	0.000632	CcSEcCtD
Levofloxacin—Back pain—Methotrexate—bone cancer	9.67e-05	0.000631	CcSEcCtD
Levofloxacin—Chills—Epirubicin—bone cancer	9.64e-05	0.000629	CcSEcCtD
Levofloxacin—Arrhythmia—Epirubicin—bone cancer	9.6e-05	0.000626	CcSEcCtD
Levofloxacin—Visual impairment—Doxorubicin—bone cancer	9.58e-05	0.000625	CcSEcCtD
Levofloxacin—Alopecia—Epirubicin—bone cancer	9.5e-05	0.000619	CcSEcCtD
Levofloxacin—TOP2A—Mitotic G1-G1/S phases—RB1—bone cancer	9.46e-05	0.00464	CbGpPWpGaD
Levofloxacin—Vomiting—Cisplatin—bone cancer	9.45e-05	0.000617	CcSEcCtD
Levofloxacin—Vision blurred—Methotrexate—bone cancer	9.42e-05	0.000614	CcSEcCtD
Levofloxacin—Mental disorder—Epirubicin—bone cancer	9.41e-05	0.000614	CcSEcCtD
Levofloxacin—Erythema multiforme—Doxorubicin—bone cancer	9.4e-05	0.000613	CcSEcCtD
Levofloxacin—Rash—Cisplatin—bone cancer	9.37e-05	0.000611	CcSEcCtD
Levofloxacin—Dermatitis—Cisplatin—bone cancer	9.36e-05	0.000611	CcSEcCtD
Levofloxacin—Erythema—Epirubicin—bone cancer	9.35e-05	0.00061	CcSEcCtD
Levofloxacin—Malnutrition—Epirubicin—bone cancer	9.35e-05	0.00061	CcSEcCtD
Levofloxacin—Eye disorder—Doxorubicin—bone cancer	9.29e-05	0.000606	CcSEcCtD
Levofloxacin—Ill-defined disorder—Methotrexate—bone cancer	9.27e-05	0.000605	CcSEcCtD
Levofloxacin—Tinnitus—Doxorubicin—bone cancer	9.27e-05	0.000605	CcSEcCtD
Levofloxacin—Anaemia—Methotrexate—bone cancer	9.24e-05	0.000603	CcSEcCtD
Levofloxacin—Flushing—Doxorubicin—bone cancer	9.23e-05	0.000602	CcSEcCtD
Levofloxacin—Cardiac disorder—Doxorubicin—bone cancer	9.23e-05	0.000602	CcSEcCtD
Levofloxacin—Flatulence—Epirubicin—bone cancer	9.22e-05	0.000601	CcSEcCtD
Levofloxacin—Tension—Epirubicin—bone cancer	9.18e-05	0.000599	CcSEcCtD
Levofloxacin—Dysgeusia—Epirubicin—bone cancer	9.16e-05	0.000598	CcSEcCtD
Levofloxacin—Nervousness—Epirubicin—bone cancer	9.09e-05	0.000593	CcSEcCtD
Levofloxacin—Back pain—Epirubicin—bone cancer	9.05e-05	0.00059	CcSEcCtD
Levofloxacin—Angiopathy—Doxorubicin—bone cancer	9.02e-05	0.000588	CcSEcCtD
Levofloxacin—Malaise—Methotrexate—bone cancer	9.01e-05	0.000588	CcSEcCtD
Levofloxacin—Muscle spasms—Epirubicin—bone cancer	8.99e-05	0.000587	CcSEcCtD
Levofloxacin—Immune system disorder—Doxorubicin—bone cancer	8.98e-05	0.000586	CcSEcCtD
Levofloxacin—Vertigo—Methotrexate—bone cancer	8.98e-05	0.000586	CcSEcCtD
Levofloxacin—Mediastinal disorder—Doxorubicin—bone cancer	8.96e-05	0.000584	CcSEcCtD
Levofloxacin—Leukopenia—Methotrexate—bone cancer	8.95e-05	0.000584	CcSEcCtD
Levofloxacin—Chills—Doxorubicin—bone cancer	8.92e-05	0.000582	CcSEcCtD
Levofloxacin—Arrhythmia—Doxorubicin—bone cancer	8.88e-05	0.000579	CcSEcCtD
Levofloxacin—Nausea—Cisplatin—bone cancer	8.83e-05	0.000576	CcSEcCtD
Levofloxacin—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	8.82e-05	0.00433	CbGpPWpGaD
Levofloxacin—Vision blurred—Epirubicin—bone cancer	8.82e-05	0.000575	CcSEcCtD
Levofloxacin—Alopecia—Doxorubicin—bone cancer	8.79e-05	0.000573	CcSEcCtD
Levofloxacin—Cough—Methotrexate—bone cancer	8.72e-05	0.000569	CcSEcCtD
Levofloxacin—Mental disorder—Doxorubicin—bone cancer	8.71e-05	0.000568	CcSEcCtD
Levofloxacin—CYP1A2—Oxidation by Cytochrome P450—CYP3A4—bone cancer	8.71e-05	0.00427	CbGpPWpGaD
Levofloxacin—Ill-defined disorder—Epirubicin—bone cancer	8.68e-05	0.000566	CcSEcCtD
Levofloxacin—Erythema—Doxorubicin—bone cancer	8.66e-05	0.000565	CcSEcCtD
Levofloxacin—Malnutrition—Doxorubicin—bone cancer	8.66e-05	0.000565	CcSEcCtD
Levofloxacin—Anaemia—Epirubicin—bone cancer	8.65e-05	0.000564	CcSEcCtD
Levofloxacin—Agitation—Epirubicin—bone cancer	8.6e-05	0.000561	CcSEcCtD
Levofloxacin—Flatulence—Doxorubicin—bone cancer	8.53e-05	0.000556	CcSEcCtD
Levofloxacin—Myalgia—Methotrexate—bone cancer	8.51e-05	0.000555	CcSEcCtD
Levofloxacin—Chest pain—Methotrexate—bone cancer	8.51e-05	0.000555	CcSEcCtD
Levofloxacin—Arthralgia—Methotrexate—bone cancer	8.51e-05	0.000555	CcSEcCtD
Levofloxacin—Tension—Doxorubicin—bone cancer	8.49e-05	0.000554	CcSEcCtD
Levofloxacin—Dysgeusia—Doxorubicin—bone cancer	8.48e-05	0.000553	CcSEcCtD
Levofloxacin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	8.45e-05	0.000551	CcSEcCtD
Levofloxacin—Malaise—Epirubicin—bone cancer	8.44e-05	0.00055	CcSEcCtD
Levofloxacin—Discomfort—Methotrexate—bone cancer	8.41e-05	0.000548	CcSEcCtD
Levofloxacin—Nervousness—Doxorubicin—bone cancer	8.41e-05	0.000548	CcSEcCtD
Levofloxacin—Vertigo—Epirubicin—bone cancer	8.4e-05	0.000548	CcSEcCtD
Levofloxacin—Syncope—Epirubicin—bone cancer	8.39e-05	0.000547	CcSEcCtD
Levofloxacin—Leukopenia—Epirubicin—bone cancer	8.37e-05	0.000546	CcSEcCtD
Levofloxacin—Back pain—Doxorubicin—bone cancer	8.37e-05	0.000546	CcSEcCtD
Levofloxacin—Muscle spasms—Doxorubicin—bone cancer	8.32e-05	0.000543	CcSEcCtD
Levofloxacin—Palpitations—Epirubicin—bone cancer	8.27e-05	0.000539	CcSEcCtD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	8.24e-05	0.00404	CbGpPWpGaD
Levofloxacin—Confusional state—Methotrexate—bone cancer	8.23e-05	0.000537	CcSEcCtD
Levofloxacin—Loss of consciousness—Epirubicin—bone cancer	8.22e-05	0.000536	CcSEcCtD
Levofloxacin—Cough—Epirubicin—bone cancer	8.16e-05	0.000532	CcSEcCtD
Levofloxacin—Anaphylactic shock—Methotrexate—bone cancer	8.16e-05	0.000532	CcSEcCtD
Levofloxacin—Vision blurred—Doxorubicin—bone cancer	8.16e-05	0.000532	CcSEcCtD
Levofloxacin—Infection—Methotrexate—bone cancer	8.1e-05	0.000529	CcSEcCtD
Levofloxacin—Hypertension—Epirubicin—bone cancer	8.08e-05	0.000527	CcSEcCtD
Levofloxacin—Ill-defined disorder—Doxorubicin—bone cancer	8.03e-05	0.000524	CcSEcCtD
Levofloxacin—SLC22A6—Transmembrane transport of small molecules—TUBB4B—bone cancer	8.01e-05	0.00393	CbGpPWpGaD
Levofloxacin—Nervous system disorder—Methotrexate—bone cancer	8e-05	0.000522	CcSEcCtD
Levofloxacin—Anaemia—Doxorubicin—bone cancer	8e-05	0.000522	CcSEcCtD
Levofloxacin—Thrombocytopenia—Methotrexate—bone cancer	7.99e-05	0.000521	CcSEcCtD
Levofloxacin—Arthralgia—Epirubicin—bone cancer	7.96e-05	0.000519	CcSEcCtD
Levofloxacin—Myalgia—Epirubicin—bone cancer	7.96e-05	0.000519	CcSEcCtD
Levofloxacin—Chest pain—Epirubicin—bone cancer	7.96e-05	0.000519	CcSEcCtD
Levofloxacin—Agitation—Doxorubicin—bone cancer	7.95e-05	0.000519	CcSEcCtD
Levofloxacin—Anxiety—Epirubicin—bone cancer	7.94e-05	0.000518	CcSEcCtD
Levofloxacin—Skin disorder—Methotrexate—bone cancer	7.92e-05	0.000517	CcSEcCtD
Levofloxacin—TOP2A—Circadian rythm related genes—CDK4—bone cancer	7.91e-05	0.00388	CbGpPWpGaD
Levofloxacin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	7.91e-05	0.000516	CcSEcCtD
Levofloxacin—Hyperhidrosis—Methotrexate—bone cancer	7.89e-05	0.000514	CcSEcCtD
Levofloxacin—Discomfort—Epirubicin—bone cancer	7.87e-05	0.000513	CcSEcCtD
Levofloxacin—Malaise—Doxorubicin—bone cancer	7.81e-05	0.000509	CcSEcCtD
Levofloxacin—Dry mouth—Epirubicin—bone cancer	7.79e-05	0.000508	CcSEcCtD
Levofloxacin—Vertigo—Doxorubicin—bone cancer	7.78e-05	0.000507	CcSEcCtD
Levofloxacin—Anorexia—Methotrexate—bone cancer	7.78e-05	0.000507	CcSEcCtD
Levofloxacin—Syncope—Doxorubicin—bone cancer	7.76e-05	0.000506	CcSEcCtD
Levofloxacin—Leukopenia—Doxorubicin—bone cancer	7.75e-05	0.000505	CcSEcCtD
Levofloxacin—Confusional state—Epirubicin—bone cancer	7.7e-05	0.000502	CcSEcCtD
Levofloxacin—Palpitations—Doxorubicin—bone cancer	7.65e-05	0.000499	CcSEcCtD
Levofloxacin—Anaphylactic shock—Epirubicin—bone cancer	7.63e-05	0.000498	CcSEcCtD
Levofloxacin—Oedema—Epirubicin—bone cancer	7.63e-05	0.000498	CcSEcCtD
Levofloxacin—Hypotension—Methotrexate—bone cancer	7.62e-05	0.000497	CcSEcCtD
Levofloxacin—Loss of consciousness—Doxorubicin—bone cancer	7.61e-05	0.000496	CcSEcCtD
Levofloxacin—TOP2A—Cell Cycle, Mitotic—DHFR—bone cancer	7.59e-05	0.00372	CbGpPWpGaD
Levofloxacin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—bone cancer	7.59e-05	0.00372	CbGpPWpGaD
Levofloxacin—Infection—Epirubicin—bone cancer	7.58e-05	0.000495	CcSEcCtD
Levofloxacin—Cough—Doxorubicin—bone cancer	7.55e-05	0.000493	CcSEcCtD
Levofloxacin—Shock—Epirubicin—bone cancer	7.51e-05	0.00049	CcSEcCtD
Levofloxacin—Nervous system disorder—Epirubicin—bone cancer	7.49e-05	0.000488	CcSEcCtD
Levofloxacin—Thrombocytopenia—Epirubicin—bone cancer	7.47e-05	0.000488	CcSEcCtD
Levofloxacin—Hypertension—Doxorubicin—bone cancer	7.47e-05	0.000487	CcSEcCtD
Levofloxacin—Tachycardia—Epirubicin—bone cancer	7.45e-05	0.000486	CcSEcCtD
Levofloxacin—Musculoskeletal discomfort—Methotrexate—bone cancer	7.43e-05	0.000485	CcSEcCtD
Levofloxacin—Skin disorder—Epirubicin—bone cancer	7.42e-05	0.000484	CcSEcCtD
Levofloxacin—Hyperhidrosis—Epirubicin—bone cancer	7.38e-05	0.000481	CcSEcCtD
Levofloxacin—Insomnia—Methotrexate—bone cancer	7.38e-05	0.000481	CcSEcCtD
Levofloxacin—Arthralgia—Doxorubicin—bone cancer	7.37e-05	0.000481	CcSEcCtD
Levofloxacin—Myalgia—Doxorubicin—bone cancer	7.37e-05	0.000481	CcSEcCtD
Levofloxacin—Chest pain—Doxorubicin—bone cancer	7.37e-05	0.000481	CcSEcCtD
Levofloxacin—Anxiety—Doxorubicin—bone cancer	7.34e-05	0.000479	CcSEcCtD
Levofloxacin—Paraesthesia—Methotrexate—bone cancer	7.33e-05	0.000478	CcSEcCtD
Levofloxacin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	7.32e-05	0.000477	CcSEcCtD
Levofloxacin—Discomfort—Doxorubicin—bone cancer	7.28e-05	0.000475	CcSEcCtD
Levofloxacin—Anorexia—Epirubicin—bone cancer	7.28e-05	0.000475	CcSEcCtD
Levofloxacin—Dyspnoea—Methotrexate—bone cancer	7.27e-05	0.000474	CcSEcCtD
Levofloxacin—Somnolence—Methotrexate—bone cancer	7.25e-05	0.000473	CcSEcCtD
Levofloxacin—Dry mouth—Doxorubicin—bone cancer	7.21e-05	0.00047	CcSEcCtD
Levofloxacin—Dyspepsia—Methotrexate—bone cancer	7.18e-05	0.000468	CcSEcCtD
Levofloxacin—CYP1A2—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	7.15e-05	0.00351	CbGpPWpGaD
Levofloxacin—Hypotension—Epirubicin—bone cancer	7.13e-05	0.000465	CcSEcCtD
Levofloxacin—Confusional state—Doxorubicin—bone cancer	7.12e-05	0.000465	CcSEcCtD
Levofloxacin—Decreased appetite—Methotrexate—bone cancer	7.09e-05	0.000463	CcSEcCtD
Levofloxacin—Oedema—Doxorubicin—bone cancer	7.06e-05	0.000461	CcSEcCtD
Levofloxacin—Anaphylactic shock—Doxorubicin—bone cancer	7.06e-05	0.000461	CcSEcCtD
Levofloxacin—Gastrointestinal disorder—Methotrexate—bone cancer	7.04e-05	0.000459	CcSEcCtD
Levofloxacin—Fatigue—Methotrexate—bone cancer	7.03e-05	0.000459	CcSEcCtD
Levofloxacin—Infection—Doxorubicin—bone cancer	7.02e-05	0.000458	CcSEcCtD
Levofloxacin—Pain—Methotrexate—bone cancer	6.98e-05	0.000455	CcSEcCtD
Levofloxacin—Musculoskeletal discomfort—Epirubicin—bone cancer	6.96e-05	0.000454	CcSEcCtD
Levofloxacin—Shock—Doxorubicin—bone cancer	6.95e-05	0.000453	CcSEcCtD
Levofloxacin—Nervous system disorder—Doxorubicin—bone cancer	6.93e-05	0.000452	CcSEcCtD
Levofloxacin—SLC22A6—Transmembrane transport of small molecules—TUBB2A—bone cancer	6.92e-05	0.00339	CbGpPWpGaD
Levofloxacin—Thrombocytopenia—Doxorubicin—bone cancer	6.92e-05	0.000451	CcSEcCtD
Levofloxacin—Insomnia—Epirubicin—bone cancer	6.9e-05	0.00045	CcSEcCtD
Levofloxacin—Tachycardia—Doxorubicin—bone cancer	6.89e-05	0.00045	CcSEcCtD
Levofloxacin—Skin disorder—Doxorubicin—bone cancer	6.86e-05	0.000448	CcSEcCtD
Levofloxacin—Paraesthesia—Epirubicin—bone cancer	6.86e-05	0.000447	CcSEcCtD
Levofloxacin—Hyperhidrosis—Doxorubicin—bone cancer	6.83e-05	0.000445	CcSEcCtD
Levofloxacin—Dyspnoea—Epirubicin—bone cancer	6.81e-05	0.000444	CcSEcCtD
Levofloxacin—TOP2A—Cell Cycle—DHFR—bone cancer	6.79e-05	0.00333	CbGpPWpGaD
Levofloxacin—Somnolence—Epirubicin—bone cancer	6.79e-05	0.000443	CcSEcCtD
Levofloxacin—Anorexia—Doxorubicin—bone cancer	6.73e-05	0.000439	CcSEcCtD
Levofloxacin—Feeling abnormal—Methotrexate—bone cancer	6.72e-05	0.000438	CcSEcCtD
Levofloxacin—Dyspepsia—Epirubicin—bone cancer	6.72e-05	0.000438	CcSEcCtD
Levofloxacin—SLC22A2—Transmembrane transport of small molecules—TUBB4B—bone cancer	6.68e-05	0.00327	CbGpPWpGaD
Levofloxacin—Gastrointestinal pain—Methotrexate—bone cancer	6.67e-05	0.000435	CcSEcCtD
Levofloxacin—Decreased appetite—Epirubicin—bone cancer	6.64e-05	0.000433	CcSEcCtD
Levofloxacin—Hypotension—Doxorubicin—bone cancer	6.6e-05	0.000431	CcSEcCtD
Levofloxacin—Gastrointestinal disorder—Epirubicin—bone cancer	6.59e-05	0.00043	CcSEcCtD
Levofloxacin—Fatigue—Epirubicin—bone cancer	6.58e-05	0.000429	CcSEcCtD
Levofloxacin—TOP2A—Retinoblastoma (RB) in Cancer—TP53—bone cancer	6.58e-05	0.00322	CbGpPWpGaD
Levofloxacin—Pain—Epirubicin—bone cancer	6.53e-05	0.000426	CcSEcCtD
Levofloxacin—Constipation—Epirubicin—bone cancer	6.53e-05	0.000426	CcSEcCtD
Levofloxacin—Urticaria—Methotrexate—bone cancer	6.48e-05	0.000423	CcSEcCtD
Levofloxacin—Body temperature increased—Methotrexate—bone cancer	6.45e-05	0.000421	CcSEcCtD
Levofloxacin—Abdominal pain—Methotrexate—bone cancer	6.45e-05	0.000421	CcSEcCtD
Levofloxacin—Musculoskeletal discomfort—Doxorubicin—bone cancer	6.44e-05	0.00042	CcSEcCtD
Levofloxacin—Insomnia—Doxorubicin—bone cancer	6.39e-05	0.000417	CcSEcCtD
Levofloxacin—Paraesthesia—Doxorubicin—bone cancer	6.34e-05	0.000414	CcSEcCtD
Levofloxacin—Dyspnoea—Doxorubicin—bone cancer	6.3e-05	0.000411	CcSEcCtD
Levofloxacin—Feeling abnormal—Epirubicin—bone cancer	6.29e-05	0.00041	CcSEcCtD
Levofloxacin—Somnolence—Doxorubicin—bone cancer	6.28e-05	0.00041	CcSEcCtD
Levofloxacin—Gastrointestinal pain—Epirubicin—bone cancer	6.24e-05	0.000407	CcSEcCtD
Levofloxacin—Dyspepsia—Doxorubicin—bone cancer	6.22e-05	0.000406	CcSEcCtD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—bone cancer	6.21e-05	0.00304	CbGpPWpGaD
Levofloxacin—Decreased appetite—Doxorubicin—bone cancer	6.14e-05	0.000401	CcSEcCtD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	6.11e-05	0.003	CbGpPWpGaD
Levofloxacin—Gastrointestinal disorder—Doxorubicin—bone cancer	6.1e-05	0.000398	CcSEcCtD
Levofloxacin—Fatigue—Doxorubicin—bone cancer	6.09e-05	0.000397	CcSEcCtD
Levofloxacin—Urticaria—Epirubicin—bone cancer	6.06e-05	0.000396	CcSEcCtD
Levofloxacin—Constipation—Doxorubicin—bone cancer	6.04e-05	0.000394	CcSEcCtD
Levofloxacin—Pain—Doxorubicin—bone cancer	6.04e-05	0.000394	CcSEcCtD
Levofloxacin—Body temperature increased—Epirubicin—bone cancer	6.04e-05	0.000394	CcSEcCtD
Levofloxacin—Abdominal pain—Epirubicin—bone cancer	6.04e-05	0.000394	CcSEcCtD
Levofloxacin—Hypersensitivity—Methotrexate—bone cancer	6.01e-05	0.000392	CcSEcCtD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	5.89e-05	0.00289	CbGpPWpGaD
Levofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—RB1—bone cancer	5.88e-05	0.00288	CbGpPWpGaD
Levofloxacin—Asthenia—Methotrexate—bone cancer	5.85e-05	0.000382	CcSEcCtD
Levofloxacin—Feeling abnormal—Doxorubicin—bone cancer	5.82e-05	0.00038	CcSEcCtD
Levofloxacin—Gastrointestinal pain—Doxorubicin—bone cancer	5.78e-05	0.000377	CcSEcCtD
Levofloxacin—Pruritus—Methotrexate—bone cancer	5.77e-05	0.000376	CcSEcCtD
Levofloxacin—SLC22A2—Transmembrane transport of small molecules—TUBB2A—bone cancer	5.77e-05	0.00283	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle—CHEK2—bone cancer	5.68e-05	0.00278	CbGpPWpGaD
Levofloxacin—Hypersensitivity—Epirubicin—bone cancer	5.62e-05	0.000367	CcSEcCtD
Levofloxacin—Urticaria—Doxorubicin—bone cancer	5.61e-05	0.000366	CcSEcCtD
Levofloxacin—Abdominal pain—Doxorubicin—bone cancer	5.58e-05	0.000364	CcSEcCtD
Levofloxacin—Body temperature increased—Doxorubicin—bone cancer	5.58e-05	0.000364	CcSEcCtD
Levofloxacin—Diarrhoea—Methotrexate—bone cancer	5.58e-05	0.000364	CcSEcCtD
Levofloxacin—CYP1A2—Phase II conjugation—GSTP1—bone cancer	5.56e-05	0.00272	CbGpPWpGaD
Levofloxacin—Asthenia—Epirubicin—bone cancer	5.48e-05	0.000357	CcSEcCtD
Levofloxacin—Pruritus—Epirubicin—bone cancer	5.4e-05	0.000352	CcSEcCtD
Levofloxacin—Dizziness—Methotrexate—bone cancer	5.39e-05	0.000352	CcSEcCtD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	5.31e-05	0.0026	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—bone cancer	5.28e-05	0.00259	CbGpPWpGaD
Levofloxacin—Diarrhoea—Epirubicin—bone cancer	5.22e-05	0.000341	CcSEcCtD
Levofloxacin—SLC22A2—Metabolism—NDUFA12—bone cancer	5.22e-05	0.00256	CbGpPWpGaD
Levofloxacin—Hypersensitivity—Doxorubicin—bone cancer	5.2e-05	0.000339	CcSEcCtD
Levofloxacin—Vomiting—Methotrexate—bone cancer	5.19e-05	0.000338	CcSEcCtD
Levofloxacin—Rash—Methotrexate—bone cancer	5.14e-05	0.000336	CcSEcCtD
Levofloxacin—Dermatitis—Methotrexate—bone cancer	5.14e-05	0.000335	CcSEcCtD
Levofloxacin—Headache—Methotrexate—bone cancer	5.11e-05	0.000333	CcSEcCtD
Levofloxacin—TOP2A—Circadian rythm related genes—JUN—bone cancer	5.1e-05	0.0025	CbGpPWpGaD
Levofloxacin—Asthenia—Doxorubicin—bone cancer	5.07e-05	0.000331	CcSEcCtD
Levofloxacin—Dizziness—Epirubicin—bone cancer	5.05e-05	0.000329	CcSEcCtD
Levofloxacin—CYP1A2—Tryptophan metabolism—MDM2—bone cancer	5.02e-05	0.00246	CbGpPWpGaD
Levofloxacin—Pruritus—Doxorubicin—bone cancer	5e-05	0.000326	CcSEcCtD
Levofloxacin—Vomiting—Epirubicin—bone cancer	4.85e-05	0.000317	CcSEcCtD
Levofloxacin—Nausea—Methotrexate—bone cancer	4.85e-05	0.000316	CcSEcCtD
Levofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—bone cancer	4.84e-05	0.00237	CbGpPWpGaD
Levofloxacin—Diarrhoea—Doxorubicin—bone cancer	4.83e-05	0.000315	CcSEcCtD
Levofloxacin—Rash—Epirubicin—bone cancer	4.81e-05	0.000314	CcSEcCtD
Levofloxacin—TOP2A—Cell Cycle—BRCA2—bone cancer	4.81e-05	0.00236	CbGpPWpGaD
Levofloxacin—Dermatitis—Epirubicin—bone cancer	4.81e-05	0.000314	CcSEcCtD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—bone cancer	4.81e-05	0.00236	CbGpPWpGaD
Levofloxacin—Headache—Epirubicin—bone cancer	4.78e-05	0.000312	CcSEcCtD
Levofloxacin—Dizziness—Doxorubicin—bone cancer	4.67e-05	0.000305	CcSEcCtD
Levofloxacin—Nausea—Epirubicin—bone cancer	4.53e-05	0.000296	CcSEcCtD
Levofloxacin—CYP1A2—Arachidonic acid metabolism—PTGS2—bone cancer	4.52e-05	0.00222	CbGpPWpGaD
Levofloxacin—Vomiting—Doxorubicin—bone cancer	4.49e-05	0.000293	CcSEcCtD
Levofloxacin—Rash—Doxorubicin—bone cancer	4.45e-05	0.000291	CcSEcCtD
Levofloxacin—Dermatitis—Doxorubicin—bone cancer	4.45e-05	0.00029	CcSEcCtD
Levofloxacin—Headache—Doxorubicin—bone cancer	4.43e-05	0.000289	CcSEcCtD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—IL3—bone cancer	4.38e-05	0.00215	CbGpPWpGaD
Levofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—bone cancer	4.36e-05	0.00214	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—NT5C3A—bone cancer	4.33e-05	0.00212	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—bone cancer	4.32e-05	0.00212	CbGpPWpGaD
Levofloxacin—SLC22A2—Transmission across Chemical Synapses—BRAF—bone cancer	4.24e-05	0.00208	CbGpPWpGaD
Levofloxacin—Nausea—Doxorubicin—bone cancer	4.2e-05	0.000274	CcSEcCtD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	4.18e-05	0.00205	CbGpPWpGaD
Levofloxacin—ABCB1—HIF-1-alpha transcription factor network—JUN—bone cancer	4.09e-05	0.00201	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle, Mitotic—CDK4—bone cancer	3.99e-05	0.00196	CbGpPWpGaD
Levofloxacin—CYP3A4—Tryptophan metabolism—MDM2—bone cancer	3.87e-05	0.0019	CbGpPWpGaD
Levofloxacin—CYP1A2—Biological oxidations—CYP3A4—bone cancer	3.8e-05	0.00186	CbGpPWpGaD
Levofloxacin—CYP1A2—Metapathway biotransformation—CYP3A4—bone cancer	3.75e-05	0.00184	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	3.66e-05	0.00179	CbGpPWpGaD
Levofloxacin—ABCB1—Transmembrane transport of small molecules—TUBB4B—bone cancer	3.65e-05	0.00179	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle—CDK4—bone cancer	3.57e-05	0.00175	CbGpPWpGaD
Levofloxacin—SLC22A2—Transmission across Chemical Synapses—MDM2—bone cancer	3.55e-05	0.00174	CbGpPWpGaD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	3.51e-05	0.00172	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle, Mitotic—RB1—bone cancer	3.47e-05	0.0017	CbGpPWpGaD
Levofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—bone cancer	3.43e-05	0.00168	CbGpPWpGaD
Levofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—bone cancer	3.43e-05	0.00168	CbGpPWpGaD
Levofloxacin—TOP2A—Circadian rythm related genes—TP53—bone cancer	3.37e-05	0.00165	CbGpPWpGaD
Levofloxacin—CYP1A2—Biological oxidations—GSTP1—bone cancer	3.25e-05	0.00159	CbGpPWpGaD
Levofloxacin—SLC22A2—Neuronal System—BRAF—bone cancer	3.25e-05	0.00159	CbGpPWpGaD
Levofloxacin—CYP1A2—Metapathway biotransformation—GSTP1—bone cancer	3.21e-05	0.00157	CbGpPWpGaD
Levofloxacin—ABCB1—Transmembrane transport of small molecules—TUBB2A—bone cancer	3.15e-05	0.00154	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle—RB1—bone cancer	3.1e-05	0.00152	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—NDUFA12—bone cancer	2.85e-05	0.0014	CbGpPWpGaD
Levofloxacin—SLC22A2—Neuronal System—MDM2—bone cancer	2.72e-05	0.00133	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	2.71e-05	0.00133	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle—MDM2—bone cancer	2.64e-05	0.0013	CbGpPWpGaD
Levofloxacin—CYP3A4—Biological oxidations—GSTP1—bone cancer	2.51e-05	0.00123	CbGpPWpGaD
Levofloxacin—CYP3A4—Metapathway biotransformation—GSTP1—bone cancer	2.47e-05	0.00121	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—NT5C3A—bone cancer	2.36e-05	0.00116	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—NDUFA12—bone cancer	2.28e-05	0.00112	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	2.01e-05	0.000986	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	1.94e-05	0.000951	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—ENO2—bone cancer	1.9e-05	0.000929	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—NT5C3A—bone cancer	1.89e-05	0.000925	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—DHFR—bone cancer	1.76e-05	0.000862	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—NDUFA12—bone cancer	1.76e-05	0.000862	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	1.75e-05	0.000857	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—GNA11—bone cancer	1.64e-05	0.000806	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle—TP53—bone cancer	1.52e-05	0.000744	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—CYP3A4—bone cancer	1.49e-05	0.00073	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—NT5C3A—bone cancer	1.46e-05	0.000714	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	1.37e-05	0.000674	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—GSTP1—bone cancer	1.27e-05	0.000625	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	1.15e-05	0.000566	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—ENO2—bone cancer	1.04e-05	0.000508	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—DHFR—bone cancer	9.61e-06	0.000471	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—GNA11—bone cancer	8.98e-06	0.00044	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—ENO2—bone cancer	8.27e-06	0.000405	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—CYP3A4—bone cancer	8.14e-06	0.000399	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—DHFR—bone cancer	7.67e-06	0.000376	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—GNA11—bone cancer	7.17e-06	0.000351	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—GSTP1—bone cancer	6.96e-06	0.000341	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—PTGS2—bone cancer	6.6e-06	0.000324	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—CYP3A4—bone cancer	6.5e-06	0.000319	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	6.47e-06	0.000317	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—ENO2—bone cancer	6.38e-06	0.000313	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—DHFR—bone cancer	5.92e-06	0.00029	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—GSTP1—bone cancer	5.56e-06	0.000272	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—GNA11—bone cancer	5.53e-06	0.000271	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—GSTP1—bone cancer	4.29e-06	0.00021	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—PTGS2—bone cancer	3.61e-06	0.000177	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—PTGS2—bone cancer	2.88e-06	0.000141	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—PTGS2—bone cancer	2.22e-06	0.000109	CbGpPWpGaD
